HomeNewsQ1 FY27 Earnings Reactions: Analyzing JSW Infra, Bandhan Bank, and Cyient DLM...

Q1 FY27 Earnings Reactions: Analyzing JSW Infra, Bandhan Bank, and Cyient DLM Performance

- Advertisement -
- Advertisement -

Earnings announcements, international regulatory approvals, and corporate dividend ex-dates are set to drive stock-specific action in Wednesday’s trading session.

MUMBAI — Indian equity markets are preparing for stock-specific movements on Wednesday, July 22, as investors digest a flurry of Q1 FY27 financial results and major corporate announcements.

Add businessleague.in as a Preferred Source

Add businessleague.in as a Preferred Source

Heading into the trading session, key market movers include JSW Infrastructure, Bandhan Bank, Cyient DLM, and Aurobindo Pharma, alongside several high-yield dividend stocks trading ex-date.

Also Read | Automated Insurance Settlement: Inside the Aarogya Setu 2.0 App Features Architecture

1. Key Earnings Reactions & Corporate Triggers

🏗️ JSW Infrastructure

  • Q1 FY27 Performance: Reported an 18.15% YoY jump in operational revenue to ₹1,444.83 crore (up from ₹1,223.85 crore), supported by a 6% increase in cargo volumes to 31 million tonnes.

  • Profitability: Consolidated net profit dipped 9.89% YoY to ₹346.63 crore due to lower other income as cash reserves were deployed toward growth capex.

🏦 Bandhan Bank

  • Q1 FY27 Performance: Net profit surged 35% YoY to ₹502 crore (compared to ₹372 crore in Q1 FY26).

  • Key Metrics: Net Interest Income (NII) grew 5.9% YoY to ₹2,921 crore. The board also approved Vinay Jain as interim CFO starting late September.

🔌 Cyient DLM

  • Q1 FY27 Performance: Posted a massive 118.2% YoY jump in net profit to ₹162.85 crore (up from ₹74.63 crore).

  • Revenue: Operational revenue expanded 34.25% YoY to ₹3,738 crore.

💊 Aurobindo Pharma

  • Regulatory Milestone: CuraTeQ Biologics, a wholly owned subsidiary, secured Good Manufacturing Practice (GMP) approval from Brazil’s ANVISA for its Hyderabad biosimilars facility.

  • Market Expansion: The approval opens up major supply opportunities across Brazil and the wider Latin American healthcare market.

Also Read | Automated Insurance Settlement: Inside the Aarogya Setu 2.0 App Features Architecture

2. Summary Table: High-Impact Stocks for July 22

Stock Symbol Key Trigger / Announcement Financial / Operational Highlight
JSWINFRA Q1 FY27 Financial Results Revenue up 18.15% to ₹1,445 Cr; PAT down 9.89% to ₹347 Cr.
BANDHANBNK Q1 FY27 Financial Results PAT jumped 35% to ₹502 Cr; NII rose 5.9% to ₹2,921 Cr.
CYIENTDLM Q1 FY27 Financial Results PAT surged 118% to ₹163 Cr; Revenue up 34% to ₹3,738 Cr.
AUROPHARMA Global Regulatory Approval ANVISA (Brazil) nod for CuraTeQ’s biosimilars facility.
IHCL (Indian Hotels) Q1 FY27 Financial Results Net profit up 27%; revenue crossed ₹2,300 crore.

3. Corporate Action: Key Ex-Dividend Stocks on July 22

Several prominent companies will trade ex-dividend on July 22, 2026. Investors buying on or after this date will not be eligible for the announced payouts:

  • Hawkins Cookers: Dividend of ₹140.00 per share.

  • Taparia Tools: Final dividend of ₹35.00 per share.

  • Aditya Birla Sun Life AMC: Final dividend of ₹25.50 per share.

  • Thangamayil Jewellery: Final dividend of ₹18.00 per share.

  • Cosmo First: Final dividend of ₹4.00 per share.

Also Read | Automated Insurance Settlement: Inside the Aarogya Setu 2.0 App Features Architecture

Add businessleague.in as a Preferred Source

Add businessleague.in as a Preferred Source
Himanshi Srivastava
Himanshi Srivastava
Himanshi, has 1 years of experience in writing Content, Entertainment news, Cricket and more. He has done BA in English. She loves to Play Sports and read books in free time. In case of any complain or feedback, please contact me @ [email protected]
RELATED ARTICLES

Most Popular

Recent Comments